Post

New research · Hematology
NPJ digital medicine · 2d
AI / informaticsNPJ digital medicine · 2026

AI-driven diagnostic algorithm enhances early detection of paroxysmal nocturnal hemoglobinuria in real-world settings.

Robert Dewor, Michal J Dabrowski, Łukasz Więcek … Grzegorz Basak
Read paper
HematologyAI / informatics

AI screening identified PNH in 10.92% of high-risk patients referred for testing.

AI-driven diagnostic algorithm enhances early detection of paroxysmal nocturnal hemoglobinuria in real-world settings.

Robert Dewor et al. · NPJ digital medicine · 2026
Methods

Retrospective analysis revealed potentially preventable diagnostic delays of 74-1337 days.

n = 1,307,140 patients
Results

PNH was diagnosed in high-risk patients referred for testing by AI screening

positive predictive va
10.92%
conventional screening
6.9%
More results

Paroxysmal nocturnal haemoglobinuria (PNH) is a rare, life-threatening hematologic disease with diagnostic delays exceeding 5 years in 24% of cases.

We developed and deployed an artificial intelligence algorithm analyzing structured and unstructured electronic health record data across 14 healthcare organizations in Poland.

More results

High-risk patients were significantly older (median 69.5 years) with elevated rates of fatigue (76.4% vs 29.19%), anaemia (72.2% vs 7.61%), and myelodysplastic syndrome (49.2% vs 0.24%; all p < 0.001).

Only 2.25% presented with haemoglobinuria versus 45-62% in registry cohorts.

“
Conclusion

Monte Carlo feature selection identified Coombs-negative haemolysis and visit frequency as strongest predictors, supporting the potential utility of AI-assisted screening for identifying atypical PNH presentations.

Read paper
0 comments

No comments yet. Be the first.

Related papers

LatestFoundational
Cohort Study
OR 3.95
flexible sigmoidoscopy makes it almost 4 times more likely to find gastrointestinal GvHD
Case-control
AUC = 0.94
CXCL9 levels accurately distinguish AML that resists treatment from remission
Cohort Study
AUC 0.939
NLR is excellent at predicting who will get lung problems after bypass surgery
Guideline
>95%
most Hairy Cell Leukemia patients have a specific gene change causing their cancer
Cohort Study
49%
Nearly half of patients had problems 30 days after spleen removal for blood cancer
Cohort Study
OR: 0.89
GLP-1RA users had slightly lower odds of Hodgkin's lymphoma than DPP-4i users
Cohort Study
adjusted hazard ratio 1.917
Patients with leukoerythroblastosis had a 1.9-fold higher hazard of 90-day death.